Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Voice

• Publication date

  2015-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jvoice.2014.08.011PMID 25242042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Considerations for Initial Dosing of Botulinum Toxin in Treatment of Adductor Spasmodic Dysphonia

  2013cited by this paper
• Botulinum Toxin Treatment of Adductor Spasmodic Dysphonia: Longitudinal Functional Outcomes

  2012cited by this paper
• Case‐control study of risk factors for spasmodic dysphonia: A comparison with other voice disorders

  2012cited by this paper
• Botulinum toxin treatment of adductor spasmodic dysphonia: Longitudinal functional outcomes

  2011cited by this paper
• Spasmodic Dysphonia: a Laryngeal Control Disorder Specific to Speech

  2011cited by this paper
• Adductor Spasmodic Dysphonia – Changes in dosing after prolonged injections

  2011cited by this paper
• The Effect of Smoking on the Dysphonia Severity Index in Females

  2010cited by this paper
• Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.

  2010cited by this paper
• Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia

  2009cited by this paper
• Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia

  2009cited by this paper
• Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection

  2008cited by this paper
• Long-Term Botulinum Toxin Dose Consistency for Treatment of Adductor Spasmodic Dysphonia

  2007cited by this paper
• Neuroimmunological activation of the afferent laryngeal neural circuit in experimentally induced laryngeal inflammation

  2005cited by this paper
• Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients

  1998cited by this paper
• The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.

  1998cited by this paper

• Assessing the effects of botulinum toxin therapy for spasmodic dysphonia: An Austria-Germany registry.

  2026cites this paper
• Managing Botulinum Toxin A Dosing for Laryngeal Dystonia.

  2025cites this paper
• Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies

  2023influential citation
• Botulinum toxin - an overview of applications in otorhinolaryngology

  2022cites this paper
• Bruksizmde Botulinum Toksini Etkinliğinin Değerlendirilmesi

  2021cites this paper
• BIROn - Birkbeck Institutional Research Online differential diagnosis management

  2021cites this paper
• Botulinum Toxin Injection for Laryngeal Disorders

  2021cites this paper
• Patient Experience Contributing to Outcomes of Laryngeal Botulinum Toxin Injection.

  2020cites this paper
• Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort

  2020cites this paper
• Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect?

  2020cites this paper
• Alternating Unilateral Versus Bilateral Injections of Botulinum Toxin for the Treatment of Adductor Spasmodic Dysphonia

  2020cites this paper
• Factors influencing long‐term treatment response to botulinum toxin injection for spasmodic dysphonia

  2020cites this paper
• Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia

  2020cites this paper
• Common practices in botulinum toxin injection for spasmodic dysphonia treatment: A national survey

  2019cites this paper
• OnabotulinumtoxinA for adductor spasmodic dysphonia (ADSD): Functional results and the role of dosage.

  2018cites this paper
• Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience

  2017cites this paper
• Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients: A Systematic Review

  2017cites this paper
• Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.

  2017cites this paper
• Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period.

  2017cites this paper
• Spasmodic dysphonia

  2017cites this paper
• Review of differential diagnosis and management of spasmodic dysphonia

  2016cites this paper
• Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15‐year experience

  2016cites this paper